copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer
(Any information to deal,buy, sell, quote for products or service)
Comparative effectiveness and safety outcomes between denosumab and . . . In real-world data reflecting clinical practice, denosumab and bisphosphonate showed comparable effectiveness for total fractures and major osteoporosis fractures, as well as safety regarding acute kidney injury, chronic kidney disease, and atypical femoral fracture
Comparison of denosumab and oral bisphosphonates for the treatment of . . . Compared with bisphosphonates, denosumab is superior in improving bone mineral density in lumbar spine and ultra-distal radius for glucocorticoid-induced osteoporosis Further studies are needed to prove the efficacy of denosumab
Denosumab compared to bisphosphonates to treat postmenopausal . . . Our meta-analysis suggested that denosumab but not bisphosphonates significantly increased change in total hip, femoral neck, lumbar spine, and one-third radius BMD for postmenopausal osteoporosis patients Current evidence suggested no benefit of denosumab for reducing risk of fracture than bisphosphonates
Bisphophonates and Denosumab are Comparable for Reducing Osteoporotic . . . Evidence from a large population-based cohort study in South Korea suggests denosumab and bisphosphonates exhibit similar efficacy and safety for preventing fractures among patients with osteoporosis, according to study results published in the Journal of Bone and Mineral Research
Denosumab vs. bisphosphonates in primary osteoporosis: a . . . - Springer We explored the comparative safety of denosumab and bisphosphonates for primary osteoporosis, some of which could be attributed to their beneficial effects However, all trials had a risk of bias Further investigations are required to confirm our results
Comparative Effectiveness and Safety Outcomes Between Denosumab and . . . In real-world data reflecting clinical practice, denosumab, and bisphosphonate showed comparable effectiveness for total fracture and osteoporosis major fracture and safety for acute kidney injury, chronic kidney disease, and atypical femoral fracture
AJOU Open Repository: Comparative effectiveness and safety outcomes . . . In real-world data reflecting clinical practice, denosumab and bisphosphonate showed comparable effectiveness for total fractures and major osteoporosis fractures, as well as safety regarding acute kidney injury, chronic kidney disease, and atypical femoral fracture
Denosumab versus Bisphosphonates for Reducing Fractures in . . . The aim of this systematic review, meta-analysis, and meta-regression is to appraise the quality of evidence and aggregate data from randomized controlled trials (RCTs) to test the hypothesis that denosumab is superior to bisphosphonates for reducing fractures in postmenopausal women with osteoporosis